INTERNATIONAL PATENT: APOGEE THERAPEUTICS, INC. FILES APPLICATION FOR "ANTIBODIES THAT BIND TSLP AND ANTIBODIES THAT BIND INTERLEUKIN 4 RECEPTOR ALPHA IN COMBINATION WITH HYALURONIDASE OR A VARIANT THEREOF"

GENEVA, April 29 -- APOGEE THERAPEUTICS, INC. (221 Crescent StreetWaltham, MA 02453) filed a patent application (PCT/US2025/051422) for "ANTIBODIES THAT BIND TSLP AND ANTIBODIES THAT BIND INTERLEUKIN 4 RECEPTOR ALPHA IN COMBINATION WITH HYALURONIDASE OR A VARIANT THEREOF" on Oct 17, 2025. With publication no. WO/2026/085414, the details related to the patent application was published on Apr 23, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): NOYES, Aaron (c/o Apogee Therapeutics, Inc.221 Crescent StreetWaltham, MA 02453), DABORA, Rebecca, Lucille (c/o Apogee Therapeutics, Inc.221 Crescent St...